Percutaneous coronary intervention for patients with type 2 diabetes mellitus: risks and novel way to manage
Open Access
- 23 June 2019
- journal article
- review article
- Published by Endocrinology Research Centre in Diabetes mellitus
- Vol. 22 (2) , 151-158
Abstract
The article is a literature review devoted to issues of planned percutaneous coronary intervention for patients with type 2 diabetes mellitus. Pathogenetic base of poor prognosis and new ways to pharmacological risk correction are described. The article highlights the trends in the incidence of carbohydrate metabolism disorders, their role in the development of complications of myocardial revascularization. The results of studies comparing different tactics of revascularization and their results in patients with different status of carbohydrate metabolism are presented. The article discusses the methods of risk management within percutaneous coronary revascularization, the role of glycemic metabolism in the risk of an poor prognosis of myocardial revascularization, describes the results of clinical trials of new drugs that can have a positive effect on the prognosis of revascularization in patients with carbohydrate metabolism disorders.Keywords
This publication has 27 references indexed in Scilit:
- Empagliflozin as Add-on to Metformin Plus Sulfonylurea in Patients With Type 2 DiabetesDiabetes Care, 2013
- Macrophage-Derived Matrix VesiclesCirculation Research, 2013
- Treatment of complex coronary artery disease in patients with diabetes: 5-year results comparing outcomes of bypass surgery and percutaneous coronary intervention in the SYNTAX trial†European Journal of Cardio-Thoracic Surgery, 2013
- Strategies for Multivessel Revascularization in Patients with DiabetesNew England Journal of Medicine, 2012
- Glycosylated hemoglobin (HbA1c) levels and clinical outcomes in diabetic patients following coronary artery stentingCardiovascular Diabetology, 2012
- A Randomized Comparison of Sirolimus- Versus Paclitaxel-Eluting Stent Implantation in Patients With Diabetes MellitusJACC: Cardiovascular Interventions, 2011
- Severe Hypoglycemia and Risks of Vascular Events and DeathNew England Journal of Medicine, 2010
- Glycosylated Hemoglobin Is a Predictor of Major Adverse Cardiac Events after Drug-Eluting Stent Implantation in Patients with Diabetes MellitusCardiology, 2010
- Prognostic Value of Hemoglobin A1C Levels in Patients With Diabetes Mellitus Undergoing Percutaneous Coronary Intervention With Stent ImplantationThe American Journal of Cardiology, 2009
- Head-to-Head Comparison of Sirolimus- and Paclitaxel-Eluting Stent in the Same Diabetic Patient With Multiple Coronary Artery LesionsDiabetes Care, 2008